- Apr. 11-13, 2012: Dr. Ron Laufer to speak at the 9th annual Pharmaceutical Strategic Outlook Conference
- Mar. 6-7, 2012: Dr. Ron Laufer to speak at the 5th annual European Life Science CEO Forum
- Dec. 13, 2011: Ambit and Astellas Announce Results from Multiple Quizartinib Presentations at 53rd Annual ASH Meeting
- Dec. 13, 2011: Catabasis Pharmaceuticals Announces $8M Series A Extension Financing
- Nov. 28, 2011: AstraZeneca Commits an Additional $100 Million to Venture Capital Arm MedImmune Ventures
- Nov. 28, 2011: Rib-X Pharmaceuticals Files Registration Statement for Proposed IPO
- Oct. 25-26, 2011: Dr. Ron Laufer spoke at BIO Investor Forum
- Oct. 21, 2011: Xencor Initiates Phase 1 Study of XmAb®5871 Therapeutic Antibody
- Oct. 16-19, 2011: Dr. Ron Laufer spoke at Ausbiotech National Conference
- Oct. 5, 2011: Catabasis Pharmaceuticals Announces Phase 1 Clinical Trial of Lead Compound
CAT-1004
News
Some of the links in this section will take you to web sites maintained by third parties. All content on the third party sites is the responsibility of the owners of the sites, including protection of your privacy, which is governed by the privacy policy of those sites. We encourage you to read the Privacy Policy of every web site you visit.